Royalty Pharma (RPRX)
Royalty Pharma Announces Pricing Of $2.0 Billion Of Senior Unsecured Notes
Ionis Pharmaceuticals Inc (IONS)
Avidity Biosciences Inc (RNA)
Royalty Pharma (RPRX)
Royalty Pharma Announces Pricing of $2.0 Billion of Senior Unsecured Notes
Inspire Medical Systems Inc. (INSP)
Coherent Inc (COHR)
Halozyme Therapeutics Inc (HALO)
Alto Neuroscience Inc. (ANRO)
ANRO STOCK NEWS: Alto Neuroscience, Inc. Investors are Reminded of the Pending Lead Plaintiff Deadline; Contact Robbins LLP for Information on Leading the Class Action
Tenet Healthcare Corporation (THC)
Becton Dickinson and Company (BDX)
Becton Dickinson and Company (BDX)
Liquidia Corporation (LQDA)
H B Fuller Company (FUL)
Biogen Inc (BIIB)
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status